MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Alpha-synuclein"

  • 2019 International Congress

    Behavioural aspect of transgenic Drosophila melanogaster as a model of Parkinson’s disease treated by Ropinirole alginate nanocomposite

    F. Naz, R. X, YHS. Siddique (Aligarh, India)

    Objective: To evaluate the behavioural changes in transgenic Drosophila melanogaster as a model of Parkinson’s disease treated by different doses of Ropinirole alginate nanocomposite (RANC).…
  • 2019 International Congress

    Decreased serum alpha-synuclein in patients with Restless Legs Syndrome and association with SNCA-Rep1 polymorphism

    YC. Wu, XY. Zhu, TT. Wu, T. Liu, HM. Wang, YJ. Chen, X. Li, XX. Cui (Shanghai, China)

    Objective: To investigate whether α -synuclein levels are altered in serum and saliva in patients with RLS and explore influence of the SNCA-Rep1 microsatellite repeat…
  • 2019 International Congress

    Impaired lysosomal catabolism of alpha-synuclein in parkinsonian LRRK2(R1441G) mutant mouse embryonic fibroblasts

    WL. Ho, CT. Leung, HF. Liu, LF. Li, DB. Ramsden, SL. Ho (Hong Kong, Hong Kong)

    Objective: Using a unique fluorescence-based flow cytometry assay on LRRK2(R1441G) mutant mouse embryonic fibroblasts (MEFs) to elucidate whether pathogenic LRRK2 mutation affects cellular lysosomal degradation…
  • 2019 International Congress

    Alpha-synuclein seeding activity in blood samples from synucleinopathy patients

    T. Yamasaki, E. Song (Lexington, KY, USA)

    Objective: Utilize a cell-based assay to determine whether a-syn seeding activity can be amplified and  detected from blood components from patients with Parkinson’s disease (PD)…
  • 2019 International Congress

    Appendectomy and risk of Parkinson’s disease: A meta-analysis using real-world evidence

    S. Hussain, A. Najmi (New Delhi, India)

    Objective: This meta-analysis is aimed to explore the association between appendectomy and Parkinson’s disease (PD) risk. Background: Parkinson’s disease is recently recognized as a systematic…
  • 2019 International Congress

    Autonomic features in E46K-SNCA carriers

    M. Carmona-Abellán, I. Gabilondo, A. Murueta, V. Khurana, R. Luquin, B. Tijero, R. Del Pino, M. Acera, R. Sanchez-Pernaute, JC. Gomez-Esteban (Bilbao, Spain)

    Objective: To evaluate structural and functional integrity of small autonomic nerve fibers and phosphorylated alpha-synuclein (p-syn) deposition in the skin of E46K-SNCA carriers as compared…
  • 2019 International Congress

    SNCA G51D missense mutation causing juvenile onset Parkinson’s disease

    C. Cooper, J. Goldman, C. Zabetian, I. Mata, J. Leverenz (Chicago, IL, USA)

    Objective: To report the clinical and genetic features in a Parkinson’s patient with the SNCA G51D missense mutation. Background: α-synuclein (SNCA) gene mutations are recognized…
  • 2019 International Congress

    High Content Screening of synucleinopathy in primary cortical neurons : dissecting out the interplay between the basic synuclein pools

    F. de Giorgi, E. Bezard, F. Ichas (Bordeaux, France)

    Objective: To set up a robust (see ref 1 for definition)  96-well High Content Screening assay of synucleinopathy in primary cultures of cortical neurons. Background:…
  • 2019 International Congress

    Utilising Magnetic Resonance Spectroscopy to investigate synucleinopathies

    N. Khalil, E. Matar, S. Duffy, S. Lewis (Camperdown, Australia)

    Objective: To study the neuronal integrity of the Anterior (ACC) and Posterior (PCC) Cingulate Cortices with Proton Magnetic Resonance Spectroscopy (H-MRS) across healthy controls (n=17),…
  • 2019 International Congress

    Ambroxol treatment of primary macrophages derived from patients with GBA-associated Parkinson’s disease

    A. Kopytova, M. Nikolaev, K. Senkevich, G. Baydakova, I. Miliukhina, E. Zakharova, S. Pchelina (Gatchina, Russian Federation)

    Objective: The aim was to evaluate the effectiveness of the restoration of GCase activity in macrophages from GBA-PD patients using pharmacological chaperone ambroxol. Background: Mutations…
  • « Previous Page
  • 1
  • …
  • 41
  • 42
  • 43
  • 44
  • 45
  • …
  • 60
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley